Fast Walking Pace Linked to Reduced Mortality
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

TUESDAY, July 29, 2025 -- Fast walking is associated with reduced mortality, according to a study published online July 29 in the American Journal of Preventive Medicine.
Lili Liu, M.P.H., from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and colleagues used data from the Southern Community Cohort Study, including information from nearly 85,000 mainly low-income and Black individuals recruited during 2002 to 2009, to examine the effect of walking pace on mortality.
The researchers found that 26,862 deaths occurred during a median follow-up of 16.7 years. All-cause mortality was significantly associated with daily fast walking time. A nearly 20 percent reduction in total mortality was seen in association with fast walking as little as 15 minutes a day, while there was only a 4 percent reduction in mortality seen in association with more than three hours of daily slow walking (hazard ratios [95 percent confidence intervals], 0.81 [0.75 to 0.87] and 0.96 [0.91 to 1.00], respectively). Regardless of leisure-time physical activity levels, fast walking was independently associated with reduced mortality. A more pronounced inverse association was seen for mortality due to cardiovascular diseases than cancers. Compared with their generally healthy counterparts, participants with baseline comorbidities had larger risk reductions, but all individuals benefited from fast walking.
"Public health campaigns and community-based programs can emphasize the importance and availability of fast walking to improve health outcomes, providing resources and support to facilitate increased fast walking within all communities," Liu said in a statement. "Individuals should strive to incorporate more intense physical activity into their routines, such as brisk walking or other forms of aerobic exercise."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-30 12:00
Read more

- Rebound Weight Gain Common After Discontinuing Antiobesity Medications
- About 1 in 3 U.S. Teens Now Have Prediabetes, New CDC Data Shows
- Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease
- Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
- Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
- 'Forever Chemicals' Identified in Reusable Feminine Hygiene Products
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions